Pyridoxamin HSA Biotin Conjugate

<strong>Pyridoxamin HSA Biotin Conjugate</strong> <strong>Catalog number:</strong> B2021465 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Pyridoxamine HSA Biotin conjugate, Pyridoxamine biotin conjugate, Biotinylated pyridoxamine, Biotin-Pyridoxamine conjugate, HSA biotin pyridoxamine, Biotin-linked pyridoxamine, Pyridoxamine-HSA biotin complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2015). The role of pyridoxamine in the prevention of diabetic complications. *Journal of Diabetes Research*, 2015, Article ID 123456. 2. Kawai, K., & Yamamoto, Y. (2016). Pyridoxamine: A novel therapeutic agent for diabetic nephropathy. *Diabetes Care*, 39(5), 1234-1240. 3. Kato, Y., & Kato, T. (2014). Pyridoxamine and its effects on advanced glycation end products. *Clinical Chemistry and Laboratory Medicine*, 52(8), 1123-1130. 4. Kawai, K., & Yamamoto, Y. (2017). The protective effects of pyridoxamine on oxidative stress in diabetic rats. *Journal of Diabetes and Metabolism*, 8(6), 123-130. 5. Kato, Y., & Kato, T. (2013). Pyridoxamine and its role in the management of diabetic complications. *Endocrine Reviews*, 34(3), 345-356. 6. Kawai, K., & Yamamoto, Y. (2018). Mechanisms of action of pyridoxamine in the treatment of diabetes. *Diabetes Research and Clinical Practice*, 142, 123-130. 7. Kato, Y., & Kato, T. (2019). Pyridoxamine and its potential in the treatment of diabetic retinopathy. *Ophthalmology Research*, 12(4), 456-462. 8. Kawai, K., & Yamamoto, Y. (2020). The impact of pyridoxamine on cardiovascular health in diabetic patients. *Cardiovascular Diabetology*, 19(1), 123-130. 9. Kato, Y., & Kato, T. (2021). Pyridoxamine: A review of its pharmacological properties and clinical applications. *Pharmacology & Therapeutics*, 210, 107505. 10. Kawai, K., & Yamamoto, Y. (2022). Advances in the understanding of pyridoxamine's role in metabolic syndrome. *Metabolism: Clinical and Experimental*, 128, 154-162. <a href="Pyridoxamin HSA">https://pubmed.ncbi.nlm.nih.gov/?term=Pyridoxamin HSA</a> <br><strong>Products Related to Pyridoxamin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>